NeuroBo Pharmaceuticals, Inc.
USD2.36
CEO
Hyung-Heon Kim
IPO Date
2016-08-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Day Low
$2.36
Day High
$2.36
52W Low
$2.36
52W High
$2.36
Market Cap
$0.02B
| 5,051 |
| $0.00 |
| 7 Jun 2024 | Glickman Mark A | director | A-Award | Acquired | 5,051 | $0.00 |
| 7 Jun 2024 | Salsbury Michael | director | A-Award | Acquired | 5,051 | $0.00 |
| 7 Jun 2024 | GROVES JASON L | director | A-Award | Acquired | 5,051 | $0.00 |
| 4 Dec 2023 | Tursi James Patrick | director | A-Award | Acquired | 7,157 | $0.00 |
| 4 Dec 2023 | Tursi James Patrick | director | A-Award | Acquired | 25,000 | $0.00 |
| 2 Nov 2023 | Tursi James Patrick | director: | Disposed | 0 | $0.00 |
| 28 Jul 2023 | KOVEN ANDREW I | director | A-Award | Acquired | 12,500 | $0.00 |
| 28 Jul 2023 | KOVEN ANDREW I | director | A-Award | Acquired | 87,500 | $0.00 |